Search Results - "Leip, Eric P"

Refine Results
  1. 1

    Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age by LLOYD-JONES, Donald M, LEIP, Eric P, LARSON, Martin G, D'AGOSTINO, Ralph B, BEISER, Alexa, WILSON, Peter W. F, WOLF, Philip A, LEVY, Daniel

    Published in Circulation (New York, N.Y.) (14-02-2006)
    “…Lifetime risk for atherosclerotic cardiovascular disease (CVD) has not previously been estimated, and the effect of risk factor burden on lifetime risk is…”
    Get full text
    Journal Article
  2. 2

    Impact of obesity on plasma natriuretic peptide levels by WANG, Thomas J, LARSON, Martin G, LEVY, Daniel, BENJAMIN, Emelia J, LEIP, Eric P, WILSON, Peter W. F, VASAN, Ramachandran S

    Published in Circulation (New York, N.Y.) (10-02-2004)
    “…The mechanisms linking obesity to hypertension have not been established, but sodium retention and excessive sympathetic tone are key contributors. The…”
    Get full text
    Journal Article
  3. 3

    Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study by Vasan, Ramachandran S, Larson, Martin G, Leip, Eric P, Kannel, William B, Levy, Daniel

    Published in The Lancet (British edition) (17-11-2001)
    “…Patients with optimum (>120/80 mm Hg), normal (120–129/80–84 mm Hg), and high normal (130–139/85–89 mm Hg) blood pressure (BP) may progress to hypertension…”
    Get full text
    Journal Article
  4. 4

    Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease by Vasan, Ramachandran S, Larson, Martin G, Leip, Eric P, Evans, Jane C, O'Donnell, Christopher J, Kannel, William B, Levy, Daniel

    Published in The New England journal of medicine (01-11-2001)
    “…Although frank hypertension is clearly associated with an increased risk of cardiovascular events, the implications of high-normal blood pressure are less…”
    Get full text
    Journal Article
  5. 5

    Framingham risk score and prediction of lifetime risk for coronary heart disease by Lloyd-Jones, Donald M, Wilson, Peter W.F, Larson, Martin G, Beiser, Alexa, Leip, Eric P, D'Agostino, Ralph B, Levy, Daniel

    Published in The American journal of cardiology (01-07-2004)
    “…We investigated whether the Framingham risk score, which was designed to estimate the 10-year risk of coronary heart disease (CHD), differentiates lifetime…”
    Get full text
    Journal Article
  6. 6

    Impact of age and sex on plasma natriuretic peptide levels in healthy adults by Wang, Thomas J, Larson, Martin G, Levy, Daniel, Leip, Eric P, Benjamin, Emelia J, Wilson, Peter W.F, Sutherland, Patrice, Omland, Torbjorn, Vasan, Ramachandran S

    Published in The American journal of cardiology (01-08-2002)
    “…Assays for natriuretic peptides have received considerable attention as potential screening tests for congestive heart failure and left ventricular…”
    Get full text
    Journal Article
  7. 7

    Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score by BALADY, Gary J, LARSON, Martin G, VASAN, Ramachandran S, LEIP, Eric P, O'DONNELL, Christopher J, LEVY, Daniel

    Published in Circulation (New York, N.Y.) (05-10-2004)
    “…The purpose of this study is to determine the usefulness of exercise treadmill testing (ETT) among asymptomatic persons in predicting coronary heart disease…”
    Get full text
    Journal Article
  8. 8

    Heritability and genetic linkage of plasma natriuretic peptide levels by Wang, Thomas J, Larson, Martin G, Levy, Daniel, Benjamin, Emelia J, Corey, Diane, Leip, Eric P, Vasan, Ramachandran S

    Published in Circulation (New York, N.Y.) (08-07-2003)
    “…Natriuretic peptides play a critical role in the maintenance of salt and water homeostasis and regulation of vascular tone. Thus, interindividual variation in…”
    Get full text
    Journal Article
  9. 9

    Novel Approach to Examining First Cardiovascular Events After Hypertension Onset by Lloyd-Jones, Donald M, Leip, Eric P, Larson, Martin G, Vasan, Ramachandran S, Levy, Daniel

    Published in Hypertension (Dallas, Tex. 1979) (01-01-2005)
    “…Hypertension confers risk for multiple types of cardiovascular events, but competing risks for these outcomes are unknown. We estimated the competing risks…”
    Get full text
    Journal Article
  10. 10

    Predictors of New-Onset Kidney Disease in a Community-Based Population by Fox, Caroline S, Larson, Martin G, Leip, Eric P, Culleton, Bruce, Wilson, Peter W. F, Levy, Daniel

    “…CONTEXT Kidney disease is associated with an increased risk for the development of cardiovascular disease and end-stage renal disease; however, risk factors…”
    Get full text
    Journal Article
  11. 11

    Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trials by Cortes, Jorge E, Dombret, Hervé, Merchant, Akil, Tauchi, Tetsuzo, DiRienzo, Christine G, Sleight, Barbara, Zhang, Xiaoxi, Leip, Eric P, Shaik, Naveed, Bell, Timothy, Chan, Geoffrey, Sekeres, Mikkael A

    Published in Future oncology (London, England) (01-11-2019)
    “…Glasdegib, an oral Hedgehog pathway inhibitor, has been associated with significantly improved survival when combined with low-dose cytarabine in patients with…”
    Get full text
    Journal Article
  12. 12

    Lifetime risk for development of atrial fibrillation : The framingham heart study by LLOYD-JONES, Donald M, WANG, Thomas J, BENJAMIN, Emelia J, LEIP, Eric P, LARSON, Martin G, LEVY, Daniel, VASAN, Ramachandran S, D'AGOSTINO, Ralph B, MASSARO, Joseph M, BEISER, Alexa, WOLF, Philip A

    Published in Circulation (New York, N.Y.) (31-08-2004)
    “…Atrial fibrillation (AF) is the most common cardiac dysrhythmia and a source of considerable morbidity and mortality, but lifetime risk for AF has not been…”
    Get full text
    Journal Article
  13. 13

    Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death by Wang, Thomas J, Larson, Martin G, Levy, Daniel, Benjamin, Emelia J, Leip, Eric P, Omland, Torbjorn, Wolf, Philip A, Vasan, Ramachandran S

    Published in The New England journal of medicine (12-02-2004)
    “…B-type natriuretic peptide and atrial natriuretic peptide are secreted by cardiac cells in response to hemodynamic stress. In the Framingham Heart Study…”
    Get full text
    Journal Article
  14. 14

    Plasma Brain Natriuretic Peptide Levels and Blood Pressure Tracking in the Framingham Heart Study by Freitag, Michael H, Larson, Martin G, Levy, Daniel, Benjamin, Emelia J, Wang, Thomas J, Leip, Eric P, Wilson, Peter W.F, Vasan, Ramachandran S

    Published in Hypertension (Dallas, Tex. 1979) (01-04-2003)
    “…ABSTRACT—Increased brain natriuretic peptide (BNP) expression in the ventricles antedates elevated blood pressure (BP) in experimental studies. We hypothesized…”
    Get full text
    Journal Article
  15. 15

    Lifetime risk for developing congestive Heart failure: The Framingham Heart Study by LLOYD-JONES, Donald M, LARSON, Martin G, LEIP, Eric P, BEISER, Alexa, D'AGOSTINO, Ralph B, KANNEL, William B, MURABITO, Joanne M, VASAN, Ramachandran S, BENJAMIN, Emelia J, LEVY, Daniel

    Published in Circulation (New York, N.Y.) (10-12-2002)
    “…Congestive heart failure (CHF) is an increasing public health problem. Among Framingham Heart Study subjects who were free of CHF at baseline, we determined…”
    Get full text
    Journal Article
  16. 16

    Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham heart Study by WANG, Thomas J, LARSON, Martin G, LEVY, Daniel, VASAN, Ramachandran S, LEIP, Eric P, WOLF, Philip A, D'AGOSTINO, Ralph B, MURABITO, Joanne M, KANNEL, William B, BENJAMIN, Emelia J

    Published in Circulation (New York, N.Y.) (17-06-2003)
    “…Atrial fibrillation (AF) and congestive heart failure (CHF) frequently occur together, but there is limited information regarding their temporal relations and…”
    Get full text
    Journal Article
  17. 17

    Does the relation of blood pressure to coronary Heart disease risk change with aging? The Framingham Heart Study by FRANKLIN, Stanley S, LARSON, Martin G, KHAN, Shehzad A, WONG, Nathan D, LEIP, Eric P, KANNEL, William B, LEVY, Daniel

    Published in Circulation (New York, N.Y.) (06-03-2001)
    “…We examined the relative importance of diastolic (DBP), systolic (SBP) and pulse pressure (PP) as predictors of coronary heart disease (CHD) risk in different…”
    Get full text
    Conference Proceeding Journal Article
  18. 18

    Predictors of new-onset diastolic and systolic hypertension the framingham heart study by FRANKLIN, Stanley S, PIO, Jose R, WONG, Nathan D, LARSON, Martin G, LEIP, Eric P, VASAN, Ramachandran S, LEVY, Daniel

    Published in Circulation (New York, N.Y.) (08-03-2005)
    “…Factors leading differentially to the development of isolated diastolic (IDH), systolic-diastolic (SDH), and isolated systolic (ISH) hypertension are poorly…”
    Get full text
    Journal Article
  19. 19

    Glycemic Status and Development of Kidney Disease: The Framingham Heart Study by Fox, Caroline S, Larson, Martin G, Leip, Eric P, Meigs, James B, Wilson, Peter W.F, Levy, Daniel

    Published in Diabetes care (01-10-2005)
    “…OBJECTIVE:--Diabetes is a major risk factor for the development of kidney disease and is the leading cause of end-stage renal disease in the U.S. Whether…”
    Get full text
    Journal Article
  20. 20

    Cross-sectional association of kidney function with valvular and annular calcification : The Framingham Heart Study by FOX, Caroline S, LARSON, Martin G, VASAN, Ramachandran S, GUO, Chao-Yu, PARISE, Helen, LEVY, Daniel, LEIP, Eric P, O'DONNELL, Christopher J, D'AGOSTINO, Ralph B, BENJAMIN, Emelia J

    “…Valvular calcification is common in the setting of end-stage kidney disease and is associated with increased risks for cardiovascular disease events. It is…”
    Get full text
    Journal Article